在非洲扩大产前多种微量营养素补充:一个统一的行动呼吁
Martin N Mwangi1, Elisabeth T Mukendi2, Carolina Pereira2
1Healthy Mothers Healthy Babies Program, Micronutrient Forum, Washington, District of Columbia, USA; Division of Human Nutrition and Health, Wageningen University & Research (Bode 62), Wageningen, The Netherlands.
Nutrition (Burbank, Los Angeles County, Calif.)
|September 5, 2025
概括
在非洲扩大产前多种微量营养素 (MMS) 补充对于改善母亲和新生儿健康至关重要. 这种干预减少了不良分娩结果, 需要综合策略才能成功广泛采用.
科学领域:
- 公共卫生营养
- 母婴健康
- 全球卫生政策
背景情况:
- 非洲的母亲营养不良是与妊娠不良结果和新生儿死亡相关的重大公共卫生问题.
- 产前多种微量营养素补充 (MMS) 是一种经过验证,具有成本效益的干预措施,以改善孕产妇和新生儿的健康状况.
- 非洲国家的MMS采用率低于最佳水平阻碍了其潜在的公共卫生影响.
研究的目的:
- 综合第二届非洲孕产妇营养和MMS技术会议的成果.
- 在非洲引入和扩大MMS的共同愿景上协调利益相关者.
- 确定可行的建议,以克服MMS实施的障碍.
主要方法:
- 一场为期三天的技术会议召集了17个非洲成员国的政府代表,捐助者和专家.
- 讨论重点是将MMS整合到产前护理中,并解决政策,供应链,融资和实施挑战.
- 制定了一份"行动呼吁",概述了扩大MMS的路线图.
主要成果:
- 强调将MMS纳入产前护理是孕产妇营养策略的基石.
- 主要信息强调了扩大MMS的紧迫性,实施科学的重要性以及区域合作的必要性.
- 概述了MMS整合,供应链质量,融资,交付强化和社区参与的途径.
结论:
- 扩大MMS是提高非洲母亲和新生儿健康的紧迫优先事项.
- 通过可执行的建议和区域合作解决发现的障碍对于成功采用MMS至关重要.
- 成功扩大MMS有助于实现性别平等和非洲的全球卫生承诺.
相关概念视频
01:26Methods Of Healthcare Delivery System
3.9K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.9K
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
383
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
383
01:16Bioavailability Enhancement: Drug Solubility Enhancement
499
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
499
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
394
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
394
01:29Drug Dosing: Infants and Children
1.0K
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
408
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408